Investigation of Nutritional Status in Chinese Patients with Common Cancer
SONG ChunHua,WANG KunHua,GUO ZengQing,FU ZhenMing,WANG Chang,WENG Min,CAO JingJing,ZHOU FuXiang,LIN Yuan,LI SuYi,BA Yi,YUAN KaiTao,LIU Ming,HU Wen,ZHOU Lan,MA Hu,YAO QingHua,CONG MingHua,LI Tao,CHEN ZiHua,CHEN GongYan,ZHAO QingChuan,LI ZengNing,FENG ChangYan,HE Ying,WU Jing,YANG JiaJun,SONG XinXia,YU YaYing,MA WenJun,LUO SuXia,ZHENG Jin,CHEN JunQiang,LUO Qi,WANG Wei,QIAO QiuGe,SHI YongMei,QI YuMei,FENG YongDong,JIANG HaiPing,QIU Hong,GUAN WenXian,CHEN JiaXin,HUANG He,YU Zhen,FANG Yu,CUI JiuWei,XU HongXia,LI Wei,SHI HanPing
DOI: https://doi.org/10.1360/ssv-2020-0297
2020-01-01
Scientia Sinica Vitae
Abstract:The negative influence of malnutrition on patients with malignant tumors runs through the whole course of a disease. To the best of our knowledge, the nutritional status of cancer patients has not yet been reported in a large sample size. Therefore, this study aimed to investigate the status of malnutrition and nutritional support therapy in a large sample of patients with common malignant tumors in China. In this observational multicenter study, 80 tertiary hospitals in 22 major provinces and cities were selected using a two-stage random sampling method. A total of 47,488 hospitalized patients with 16 kinds of common malignant tumors were enrolled in this study. The nutritional status of the patients was assessed by the scored Patient-Generated Subjective Global Assessment (PG-SGA). The severity of malnutrition was identified by a quantitative assessment where 0–1 was labelled as no malnutrition and 2–3, 4–8, and ≥9 were defined as suspected/mild, moderate and severe malnutrition. The PG-SGA scores of patients with different tumor characteristics were compared by a variance analysis. The incidence rate of moderate and severe malnutrition was 58.2%, of which 32.1% and 26.1% fell under the category of moderate and severe malnutrition, 22.2% were suspected/mild and only 19.6% of the sample were not malnourished. The incidence of malnutrition varied in respect to tumor species, age, gender, tumor stage, treatment and region: The PG-SGA score of pancreatic cancer patients was the highest (9.58±5.74), and that of breast cancer patients was the lowest (3.51±3.49); The PG-SGA score of vs. 5.60, P = 0.006) and gastric cancer (8.36 vs. 7.81, P